US Equity · NYSE · Earnings Dossier

JNJ earnings intelligence

Johnson & Johnson

Healthcare · Drug Manufacturers - General · USD reporting basis

Current earnings profile Mixed earnings transmission

Delivery and market response do not currently form a persistent directional pattern.

Evidence100/100 · Deep

Next scheduled catalyst

Tuesday 13 October 2026

Time unconfirmed · Fiscal period ending 30 Sep 2026

16event risk

Contained

Countdown61 dayscalendar proximity
EPS estimate3.05 USDprovider consensus
Estimate growth+8.9%versus comparable year-ago actual
Historical movement1.9%average absolute next weekly close

Three-year earnings transmission

Delivered earnings power versus market price

Expectations ahead

Market price is leading earnings power; the spread is widening and has persisted through 4 updates. Both series begin at 100, so the gap isolates the relative change in price and trailing earnings power.

Market move64.0%2023-08-18 to 2026-08-07
Earnings move4.6%trailing diluted EPS
Unresolved spread-59.4 ptsWidening
Current multiple23.9xprice divided by TTM EPS
Relationship pressure61/100Moderate
Model confidence96/100High

Move decomposition

Earnings contribution and valuation offset

The market move is separated into the change in trailing earnings power and the offset from relative valuation.

Relationship controls

What qualifies the headline spread

Business quality supportive

Cash generation and operating evidence are broadly supportive.

Expectations elevated

Price is leading delivered earnings power by a meaningful margin.

Beat rate83.3%10 beats in 12 measured quarters
Average surprise+3.2%median 2.2%
Delivery streak22 consecutive beats
Average response+0.7%12 measured reactions
Result-price confirmation63%same directional sign
Surprise variability2.8 ptspopulation dispersion

Estimate delivery

Actual EPS versus consensus

Actual and estimated EPS are displayed in reported currency on the same quarterly basis.

Price acceptance

Surprise and next weekly close

The response uses the first completed weekly close after the public report against the prior completed weekly close.

Fundamental delivery

Quarterly revenue and net income

Reported financial statements provide scale and earnings quality context around the headline EPS result.

Transmission matrix

Does price confirm delivery?

Upper right and lower left observations confirm the sign of delivery. The other quadrants expose expectation or resilience effects.

Current business context

Growth, quality and valuation

As of 9 Aug 2026
EPS growth-7.2%year on year
Revenue growth8.1%year on year
Average surprise1.1%latest four quarters
SUE0.96standardised surprise
Net margin21.5%trailing basis
Cash conversion1.36xcash flow / net income
P/E29.7xcurrent snapshot
Data completeness100%alphavantage

Market context

Positioning into the event

Week ending 7 Aug 2026
Weekly close259.24 USDcompleted week
13-week return17.8%price momentum
Fair-value gap51.4%price versus current fair value
Relative strength6.5exchange benchmark
Trend signalActiveweekly architecture
Next-week stateUndecided50.4%

Market context describes the setup surrounding the report. It does not convert the earnings event into a directional forecast.

Reported evidence ledger

Quarter-by-quarter delivery and acceptance

Each row preserves the reported estimate, public date, statement context and conservative weekly reaction measurement.

12 quarters
Reported / periodEPS actual / estimateSurpriseEPS growthRevenue / growthNext close / four weeksRead
Reported / period15 Jul 202630 Jun 2026 · exact
EPS actual / estimate2.90 / 2.84USD
Surprise+2.1%Beat
EPS growth+4.7%year on year
Revenue / growth25310000000+6.6% · USD
Next close / four weeks-1.5% / +0.9%completed weekly closes
ReadDivergedresult versus price sign
Reported / period14 Apr 202631 Mar 2026 · exact
EPS actual / estimate2.70 / 2.68USD
Surprise+0.7%Beat
EPS growth-2.5%year on year
Revenue / growth24062000000+9.9% · USD
Next close / four weeks-1.8% / -7.2%completed weekly closes
ReadDivergedresult versus price sign
Reported / period21 Jan 202631 Dec 2025 · exact
EPS actual / estimate2.46 / 2.46USD
Surprise0.0%In-Line
EPS growth+20.6%year on year
Revenue / growth24564000000+9.1% · USD
Next close / four weeks+0.7% / +11.3%completed weekly closes
ReadContainedresult versus price sign
Reported / period14 Oct 202530 Sep 2025 · exact
EPS actual / estimate2.80 / 2.76USD
Surprise+1.4%Beat
EPS growth+15.7%year on year
Revenue / growth23993000000+6.8% · USD
Next close / four weeks+1.3% / -2.2%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period16 Jul 202530 Jun 2025 · exact
EPS actual / estimate2.77 / 2.68USD
Surprise+3.4%Beat
EPS growth-1.8%year on year
Revenue / growth23743000000+5.8% · USD
Next close / four weeks+4.3% / +10.5%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period15 Apr 202531 Mar 2025 · exact
EPS actual / estimate2.77 / 2.58USD
Surprise+7.4%Beat
EPS growth+2.2%year on year
Revenue / growth21893000000+2.4% · USD
Next close / four weeks+3.8% / +1.6%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period22 Jan 202531 Dec 2024 · exact
EPS actual / estimate2.04 / 2.01USD
Surprise+1.5%Beat
EPS growth-10.9%year on year
Revenue / growth22520000000+5.3% · USD
Next close / four weeks-0.1% / +6.2%completed weekly closes
ReadContainedresult versus price sign
Reported / period15 Oct 202430 Sep 2024 · exact
EPS actual / estimate2.42 / 2.21USD
Surprise+9.5%Beat
EPS growth-9.0%year on year
Revenue / growth22471000000+5.2% · USD
Next close / four weeks+2.3% / -3.7%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period17 Jul 202430 Jun 2024 · exact
EPS actual / estimate2.82 / 2.70USD
Surprise+4.4%Beat
EPS growth-year on year
Revenue / growth22447000000- · USD
Next close / four weeks+3.2% / +7.2%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period16 Apr 202431 Mar 2024 · exact
EPS actual / estimate2.71 / 2.65USD
Surprise+2.3%Beat
EPS growth-year on year
Revenue / growth21383000000- · USD
Next close / four weeks+0.3% / +1.6%completed weekly closes
ReadContainedresult versus price sign
Reported / period23 Jan 202431 Dec 2023 · exact
EPS actual / estimate2.29 / 2.28USD
Surprise+0.4%In-Line
EPS growth-year on year
Revenue / growth21395000000- · USD
Next close / four weeks-1.3% / -2.4%completed weekly closes
ReadContainedresult versus price sign
Reported / period17 Oct 202330 Sep 2023 · exact
EPS actual / estimate2.66 / 2.52USD
Surprise+5.6%Beat
EPS growth-year on year
Revenue / growth21351000000- · USD
Next close / four weeks-2.5% / -6.1%completed weekly closes
ReadDivergedresult versus price sign

Reproducible method

How the earnings dossier is measured

Descriptive, not predictive
Estimate delivery

Reported diluted EPS is compared with the stored estimate for the same fiscal period. Moves within ±0.5% are classified as in-line.

Price response

The first completed weekly close after the public date is compared with the prior completed weekly close. Four-week response uses the first close at least 21 days later.

Event risk

Risk combines proximity, average absolute price movement, surprise variability, estimate availability and timing certainty. It does not score direction.

Data discipline

Exact public dates are used when stored. Missing estimates, timing and statement fields remain missing. No result or reaction is filled from a future observation.

Independent market research for education. Not investment advice, a recommendation, forecast, target or execution instruction.

Evidence context